Biologics: end-to-end formulation

Article

Sponsored Content

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion. However, getting a promising drug candidate can be daunting. This white paper details how to optimize formulation development and tech transfer to ensure successful biologics production.

Related Content
© 2024 MJH Life Sciences

All rights reserved.